Literature DB >> 21947377

Osteoporotic hip fractures in non-elderly patients: relevance of associated co-morbidities.

Sandra G Pasoto1, Liz A K Yoshihara, Lucy C Maeda, Marcia M S Bernik, Paulo A Lotufo, Eloisa Bonfa, Rosa M R Pereira.   

Abstract

Osteoporotic hip fractures (OHF) are not limited to elderly; however, studies in non-elderly are scarce. Thus, the aim of this study was to evaluate co-morbidities in non-elderly patients with OHF in a Community Teaching Hospital. All hospitalizations due to OHF during a 3-year period in a Community Teaching Hospital were retrospectively evaluated for co-morbidities, and patients 18-64 years old were compared with those ≥65 years old. Of all hospitalizations, 232 (0.73%) were due to hip fractures, and 120/232 (51.7%) patients had OHF. The comparison of the 13 (10.8%) OHF patients <65 years old (47.3 ± 9.7 years) with 107 (89.2%) ≥65 years old (80.4 ± 7.7 years) revealed a male predominance (61.5 vs. 27.1%, P = 0.022) and a distinct ethnic distribution with a lower proportion of Caucasians in the former (61.5 vs. 86.9%, P = 0.033). Moreover, non-elderly OHF patients had higher frequencies of insulin-dependent DM (38.5 vs. 3.7%, P = 0.001) and alcoholism (38.5 vs. 4.7%, P = 0.001) than aged patients. In contrast, rates of age-related co-morbidities such as stroke (7.7 vs. 18.7%, P = 0.461), heart failure (23.1 vs. 14.0%, P = 0.411), and dementia (7.7 vs. 15.9%, P = 0.689) were comparable in both groups. Logistic regression analysis demonstrated that insulin-dependent DM (OR = 25.4, 95% CI = 4.7-136.8, P < 0.001) and alcoholism (OR = 20.3, 95% CI = 3.9-103.3, P < 0.001) remained as independent risk factors for OHF in non-elderly patients. Osteoporosis is an important cause of HF in Community Hospital. Non-elderly patients with OHF have a peculiar demographic profile and associated co-morbidities. These findings reinforce the need of early osteoporosis diagnosis and rigorous fracture prevention in patients with DM and alcoholism.

Entities:  

Mesh:

Year:  2011        PMID: 21947377     DOI: 10.1007/s00296-011-2154-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

Review 1.  Drug-induced osteoporosis: mechanisms and clinical implications.

Authors:  Gherardo Mazziotti; Ernesto Canalis; Andrea Giustina
Journal:  Am J Med       Date:  2010-10       Impact factor: 4.965

2.  Risk factors for cardiovascular disease in a Brazilian population-based cohort study.

Authors:  Renan Stoll Moraes; Flávio Danni Fuchs; Leila Beltrami Moreira; Mário Wiehe; Gerson Martins Pereira; Sandra Costa Fuchs
Journal:  Int J Cardiol       Date:  2003-08       Impact factor: 4.164

3.  Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey.

Authors:  L Forsén; H E Meyer; K Midthjell; T H Edna
Journal:  Diabetologia       Date:  1999-08       Impact factor: 10.122

Review 4.  Epidemiology of hip fractures.

Authors:  P Kannus; J Parkkari; H Sievänen; A Heinonen; I Vuori; M Järvinen
Journal:  Bone       Date:  1996-01       Impact factor: 4.398

5.  Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study.

Authors:  M M Campos Pastor; P J López-Ibarra; F Escobar-Jiménez; M D Serrano Pardo; A G García-Cervigón
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

Review 6.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

7.  Type 2 diabetes: prevalence and associated factors in a Brazilian community--the Bambuí health and aging study.

Authors:  Valéria Maria de Azeredo Passos; Sandhi Maria Barreto; Leonardo Maurício Diniz; Maria Fernanda Lima-Costa
Journal:  Sao Paulo Med J       Date:  2005-06-08       Impact factor: 1.044

8.  Cardiovascular diseases and risk of hip fracture.

Authors:  Ulf Sennerby; Håkan Melhus; Rolf Gedeborg; Liisa Byberg; Hans Garmo; Anders Ahlbom; Nancy L Pedersen; Karl Michaëlsson
Journal:  JAMA       Date:  2009-10-21       Impact factor: 56.272

9.  Insufficiency fractures of both femoral necks in a young adult caused by osteoporosis: a case report.

Authors:  Aydiner Kalaci; Ahmet Nedim Yanat; Teoman Toni Sevinç; Yunus Doğramaci
Journal:  Arch Orthop Trauma Surg       Date:  2008-05-01       Impact factor: 3.067

10.  Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study.

Authors:  Cynthia L Leibson; Anna N A Tosteson; Sherine E Gabriel; Jeanine E Ransom; L Joseph Melton
Journal:  J Am Geriatr Soc       Date:  2002-10       Impact factor: 5.562

View more
  8 in total

1.  The role of vitamin D in the metabolic homeostasis of diabetic bone.

Authors:  Kathryn M Thrailkill; John L Fowlkes
Journal:  Clin Rev Bone Miner Metab       Date:  2013-03-01

2.  Maternal vitamin D beneficially programs metabolic, gut and bone health of mouse male offspring in an obesogenic environment.

Authors:  C R Villa; J Chen; B Wen; S M Sacco; A Taibi; W E Ward; E M Comelli
Journal:  Int J Obes (Lond)       Date:  2016-10-04       Impact factor: 5.095

3.  Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- mice.

Authors:  Kelly E Mercer; Clark R Sims; Carrie S Yang; Rebecca A Wynne; Christopher Moutos; William R Hogue; Charles K Lumpkin; Larry J Suva; Jin-Ran Chen; Thomas M Badger; Martin J J Ronis
Journal:  Alcohol Clin Exp Res       Date:  2013-11-20       Impact factor: 3.455

4.  Assessing outcomes in hip fracture patients under the age of 60.

Authors:  David Keohane; Laith Al Azawi; Colum Downey; John F Quinlan
Journal:  Ir J Med Sci       Date:  2021-02-12       Impact factor: 1.568

5.  Low bone density and high morbidity in patients between 55 and 70 years with displaced femoral neck fractures: a case-control study of 50 patients vs 150 normal controls.

Authors:  Stefan Bartels; Jan-Erik Gjertsen; Frede Frihagen; Cecilia Rogmark; Stein Erik Utvåg
Journal:  BMC Musculoskelet Disord       Date:  2019-08-14       Impact factor: 2.362

6.  Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice.

Authors:  Kelly E Mercer; Rebecca A Wynne; Oxana P Lazarenko; Charles K Lumpkin; William R Hogue; Larry J Suva; Jin-Ran Chen; Andrew Z Mason; Thomas M Badger; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2012-08-14       Impact factor: 4.030

7.  Genistein supplementation increases bone turnover but does not prevent alcohol-induced bone loss in male mice.

Authors:  Carrie S Yang; Kelly E Mercer; Alexander W Alund; Larry J Suva; Thomas M Badger; Martin J J Ronis
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-28

8.  Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens.

Authors:  Ella T Nkhoma; Lisa Rosenblatt; Joel Myers; Angelina Villasis-Keever; John Coumbis
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.